Literature DB >> 22994601

Dialysate quality: new standards require a new approach to compliance.

David A Fendley1, Richard A Ward.   

Abstract

Substances commonly found in drinking water can injure hemodialysis patients if they are not removed from the water during the preparation of dialysate. Standards have been developed that specify the maximum allowable levels of these substances in dialysate. Those standards have recently been revised. While the maximum allowable levels of chemical contaminants have not changed, a more sensitive method for bacterial cultures has been specified and the maximum allowable levels of bacteria and endotoxin in the new standards have been decreased. These decreases are a consequence of an increasing body of evidence that improving dialysate quality positively impacts patient outcomes. Meeting the new microbiological standards could require dialysis facilities to adopt new approaches to managing their water treatment and concentrate preparation systems. To address this need, the new standards present a framework for developing a facility-specific quality management system for ensuring dialysate quality based on validation of system performance, coupled with routine monitoring and periodic revalidation of performance.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22994601     DOI: 10.1111/sdi.12007

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  2 in total

Review 1.  Maintaining safety in the dialysis facility.

Authors:  Alan S Kliger
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-06       Impact factor: 8.237

2.  Serum trace metal association with response to erythropoiesis stimulating agents in incident and prevalent hemodialysis patients.

Authors:  Michael E Brier; Jessica R Gooding; James M Harrington; Jason P Burgess; Susan L McRitchie; Xiaolan Zhang; Brad H Rovin; Jon B Klein; Jonathan Himmelfarb; Susan J Sumner; Michael L Merchant
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.